Market Overview:
The global scar treatment drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of skin injuries and rising awareness about available treatment options. In addition, the growing demand for minimally invasive procedures is also contributing to the growth of this market. Based on type, the global scar treatment drugs market can be segmented into creams, gels, scar sheets, and other products. The creams segment is expected to account for a major share of this market in 2018 owing to their high efficacy and ease of use. By application, the hospital segment is expected to dominate this market in 2018 followed by home use and dermatology clinics segments respectively.
Product Definition:
Scar treatment drugs are medicines that are used to improve the appearance of scars. They work by breaking down collagen in the scar tissue and promoting new collagen growth. This can help make the scar less noticeable.
Creams:
Creams are topical medicines used for the treatment of scars. They are available in various forms such as gels, creams, and ointments. The active ingredients in these products include retinoids, alpha-hydroxy acids (AHA), and hydroxy acids (HA). Products with a high concentration of these active ingredients help reduce the appearance of deep wrinkles and facial lines.
Gels:
Gels are a group of cosmetic products that consist of water-based or oil-based solutions that are semi solid to completely liquid at room temperature. They have the ability to change their physical appearance and provide various benefits such as moisturizing, soothing, and cooling.
Application Insights:
Based on the application, the market is segmented into hospital use, dermatology clinics use and home use. The hospital-based treatment is used for severe burns injuries. The home-use scar treatment drugs are primarily used for treating acute wounds at home without having to go to a dermatology clinic or hospital.
The demand for scar management products in Asia Pacific is expected to be driven by factors such as increasing number of plastic surgeries performed locally and growing aging population with skin conditions that require surgical scars management drugs. In addition, a rising preference towards minimally invasive procedures coupled with high disposable income levels in countries like China and India will further propel market growth over the forecast period.
On the other hand, Europe will witness significant growth owing to increasing healthcare spending due to rise in geriatric population along with an increase in burn injury cases resulting from cooking accidents or firecrackers during Diwali festivities across various cities of India such as Surat.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of burns and trauma, rising awareness about scar treatment options, availability of skilled professionals, and high adoption rate for advanced products.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to factors such as improving healthcare infrastructure & reimbursement scenario in developing countries like India & China. Moreover, an increase in international tourism has led to a rise in burn injuries which will boost demand for scar treatment drugs leading to regional growth over the forecast period.
In addition, growing medical tourism industry coupled with favorable government policies regarding medical treatments may also contribute towards future revenue generation prospects for this regional segmentation.
Growth Factors:
- Increasing incidence of skin injuries and scars due to accidents or surgeries
- Growing awareness about the benefits of scar treatment drugs among consumers
- Rising demand for minimally invasive procedures for scar treatment
- Technological advancements in the field of scar treatment drugs and devices
- Availability of a wide range of scar treatment drugs and devices in the market
Scope Of The Report
Report Attributes
Report Details
Report Title
Scar Treatment Drugs Market Research Report
By Type
Creams, Gels, Scar Sheets, Other
By Application
Hospital, Home Use, Dermatology Clinics
By Companies
Perrigo Company, Smith & Nephew, Alliance Pharma, Rejûvaskin, HRA Pharma, Molnlycke Health Care, Sonoma Pharmaceuticals, Sientra, Pacific World Corporation, CCA Industries, Velius
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Scar Treatment Drugs Market Report Segments:
The global Scar Treatment Drugs market is segmented on the basis of:
Types
Creams, Gels, Scar Sheets, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Home Use, Dermatology Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Perrigo Company
- Smith & Nephew
- Alliance Pharma
- Rejûvaskin
- HRA Pharma
- Molnlycke Health Care
- Sonoma Pharmaceuticals
- Sientra
- Pacific World Corporation
- CCA Industries
- Velius
Highlights of The Scar Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Creams
- Gels
- Scar Sheets
- Other
- By Application:
- Hospital
- Home Use
- Dermatology Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Scar Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Scar treatment drugs are medications that are used to reduce the appearance of scars. Scar treatment drugs can be applied topically or taken by mouth.
Some of the major players in the scar treatment drugs market are Perrigo Company, Smith & Nephew, Alliance Pharma, Rej»vaskin, HRA Pharma, Molnlycke Health Care, Sonoma Pharmaceuticals, Sientra, Pacific World Corporation, CCA Industries, Velius.
The scar treatment drugs market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Scar Treatment Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Scar Treatment Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Scar Treatment Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Scar Treatment Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Scar Treatment Drugs Market Size & Forecast, 2020-2028
4.5.1 Scar Treatment Drugs Market Size and Y-o-Y Growth
4.5.2 Scar Treatment Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Creams
5.2.2 Gels
5.2.3 Scar Sheets
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Home Use
6.2.3 Dermatology Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Scar Treatment Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Scar Treatment Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Creams
9.6.2 Gels
9.6.3 Scar Sheets
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Home Use
9.10.3 Dermatology Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Creams
10.6.2 Gels
10.6.3 Scar Sheets
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Home Use
10.10.3 Dermatology Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Creams
11.6.2 Gels
11.6.3 Scar Sheets
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Home Use
11.10.3 Dermatology Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Creams
12.6.2 Gels
12.6.3 Scar Sheets
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Home Use
12.10.3 Dermatology Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Creams
13.6.2 Gels
13.6.3 Scar Sheets
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Home Use
13.10.3 Dermatology Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Scar Treatment Drugs Market: Competitive Dashboard
14.2 Global Scar Treatment Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Perrigo Company
14.3.2 Smith & Nephew
14.3.3 Alliance Pharma
14.3.4 Rejûvaskin
14.3.5 HRA Pharma
14.3.6 Molnlycke Health Care
14.3.7 Sonoma Pharmaceuticals
14.3.8 Sientra
14.3.9 Pacific World Corporation
14.3.10 CCA Industries
14.3.11 Velius
